SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

Loading...
FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

IHC Research

  • CLIENT LOGIN
  • LARGE FILE TRANSFER
  • LOGIN
  • Home
  • About IHC Research
    • IHC Management
    • Resourcing Partnerships
  • Clinical Expertise
    • Medical Devices
    • Rx – Phase I to IV
    • OTC Consumer Healthcare
  • IHC Services
    • Project Management
    • Site Management/Monitoring
    • Medical Writing
    • Regulatory Affairs
    • Safety/Ethics Review
    • Data Management / Biostatistics
    • Communication & Training
    • Problem Solvers
  • Contact Us
  • Home
  • About IHC Research
  • IHC Management

IHC Management

IHC Management

Peter A. Fratarcangelo, Ph.D. – CEO

Peter Fratarcangelo has more than 40 years experience in the clinical research of Rx, OTC, & Rx-to-OTC switch compounds. As CEO of International HealthCare and International Pharmaceutical Research (a mid-size CRO), Peter has guided the research of more than 150 compounds. He has been successful in designing, coordinating and implementing entire clinical programs for 10 Rx-to-OTC switches & 7 Rx – NDA programs, 3 NCE agents, one biologic and two medical devices. As Director of Research, Peter successfully guided the clinical development and provided the pivotal research for many important new drugs now on the market.  Examples of such are:

  • Pepcid-AC®
  • Zantac-75®
  • Tagamet-HB®
  • Axid-AR®
  • Imodium-AD®
  • Carafate®
  • Gyne-Lotrimin®
  • Mycelex®
  • Nicorette Gum®
  • Children’s Motrin®
  • Angiomax®
  • Aricept®
  • Lorabid®
  • Preparation-H®
  • Maalox®
  • Massengill®
  • Zofran®
  • Immetrix®
  • Children’s & Extra Strength Tylenol®
  • Crest Sensitive®
  • Promise®
  • Aqua-Fresh Sensitive® toothpaste
  • Robaxin®

Peter has presented more than forty papers and clinical reports at symposiums and conferences covering the wide range of therapeutic areas evident in his research referenced above. Peter is also a frequent speaker at International Research Conferences, training the attendees on the design of clinical studies for Rx-to-OTC Switching, proper clinical site management and Good Clinical Practices. Before starting his CRO in 1984, Peter worked as Associate Director of Rx Clinical Research in the New Drug Development Department at Pfizer Pharmaceuticals and in the OTC arena as Associate Director-Personal Products at Richardson-Vicks, Inc. Peter holds a B.S. degree from Manhattan College, an MS from NYU, and a Ph.D. from CPU. He is an associate member of the CHPA, a member of the Drug Information Association and a charter member of the National Institute for Infectious Disease.

William K. Tobin – President

Bill Tobin has been IHC’s President since CRO inception in 2001.  Bill has been conducting and managing clinical trials for drugs, biologics, tissue and medical devices in a wide range of therapeutic areas since 1994. Prior to joining International HealthCare, Bill served as Clinical Project Manager at Purdue Pharma, LLP in Stamford, CT.  While at Purdue he managed a newly developed local anesthetic product and later was promoted to manage clinical trials for OxyContin. Initially entering the medical research field as a Clinical Research Associate at International Pharmaceutical Research, a CRO based in Norwalk, CT, Bill became key to the company’s growth to over 100 clinical scientists, SAS programmers and statisticians. His role and responsibilities included project planning, protocol development, investigator selection, project implementation and data analysis for many successful NDA programs. He also held positions as Project Manager and Associate Director of New Business Development. Bill has the unique experience as a clinical program manager for both a large Pharma and a mid-size CRO and has managed successful large scale domestic and international programs.

Bill is a member of various industry associations and maintains his knowledge of Good Clinical Practices and FDA guidance’s through continuous industry provided training.  A graduate of Providence College with a B.S. in biology, and MPH  in epidemiology from New York Medical College.

About IHC Research

  • IHC Management
  • Resourcing Partnerships
  • Contact Us
  • Download IHC Brochure

Experienced. Dedicated. Global.

International HealthCare (IHC) is a full service contract research organization (CRO) and product development company providing clinical trials and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide.

Our History of Success

  • Treatment for and Related Conditions Associated with Rhinitis, Asthma, Colds, Coughs

    This review will highlight drugs in the cough/c...
  • Diarrhea, Constipation: Treatment & Related Conditions

    This review will highlight IHC’s expertise as y...
  • Heartburn Treatment & Prevention

    This review will highlight items to consider be...

CLINICAL EXPERTISE

  • Medical Devices
  • Rx – Phase I to IV
  • OTC Consumer Healthcare

IHC SERVICES

  • Project Management
  • Site Management & Monitoring
  • Medical Writing
  • Regulatory Affairs
  • Safety/Ethics Review
  • Data Management / Biostatistics
  • Communication & Training
  • Problem Solvers

ABOUT US

  • IHC Management
  • Resourcing Partnerships
  • Contact Us
  • Download IHC Brochure
IHC provides clinical research services, regulatory strategy and product development for pharmaceutical, biotechnology, and medical device industries. We can assist in designing, monitoring, and managing all phases of your clinical trial.
  • GET SOCIAL

© 2020 International HealthCare (IHC) | 98 East Avenue | Norwalk, CT 06851
Phone: (203) 852-8900   |   Email: [email protected]

TOP